Sign Up to like & get
recommendations!
0
Published in 2024 at "Expert Opinion on Drug Delivery"
DOI: 10.1080/17425247.2024.2305110
Abstract: ABSTRACT Background Exendin-4 (Ex4) is a promising drug for diabetes mellitus with a half-life of 2.4 h in human bodies. Besides, the Ex4 formulations currently employed in the clinic or under development have problems pertaining to…
read more here.
Keywords:
mvls;
stability;
palmitic acid;
pal ex4 ... See more keywords